50 Participants Needed

Health Program for Breast Cancer Survivors

IL
Overseen ByIvan Leung@ucsf.edu
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This is a pilot study testing multi-disciplinary health behavior intervention in breast cancer survivors who have been treated at Zuckerberg San Francisco General (ZSFG).

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment HEART-ACT for breast cancer survivors?

Research shows that interventions using wearable activity trackers and health coaching can help breast cancer survivors increase physical activity and reduce sedentary behavior, which are important for improving overall health and quality of life. Additionally, online walking programs have been shown to improve physical fitness, blood pressure, and mental health in cancer survivors.12345

Is the Health Program for Breast Cancer Survivors safe for participants?

The research does not provide specific safety data for the Health Program for Breast Cancer Survivors, but it highlights the importance of monitoring cardiovascular health in breast cancer survivors, especially those receiving treatments that may affect the heart.25678

How does this treatment for breast cancer survivors differ from other treatments?

This treatment is unique because it uses wearable technology, like the Garmin Vivofit 2 activity monitor, combined with health coaching to encourage breast cancer survivors to be more active and reduce sitting time, which is different from traditional treatments that may not focus on lifestyle changes.235910

Research Team

AB

Alexis Beatty, MD, MAS

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for breast cancer survivors over 18 who can communicate in English, Spanish, or Cantonese. Participants must have been treated with the intent to cure at Zuckerberg San Francisco General Hospital and not be planning further chemotherapy, radiation, or surgery within the next three months.

Inclusion Criteria

Able to consent for self
Receive care at Zuckerberg San Francisco General Hospital
My treatment was aimed at curing my condition.
See 1 more

Exclusion Criteria

You are expected to live for less than 1 year.
I am scheduled for chemotherapy, radiation, or surgery within the next 3 months.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 12-week multi-disciplinary health behavior program with individualized assessments and plans

12 weeks
Weekly sessions alternating between group and individual

Follow-up

Participants are monitored for changes in health outcomes at 3, 6, and 12 months

12 months

Treatment Details

Interventions

  • HEART-ACT
Trial Overview The HEART-ACT study tests a health behavior intervention for breast cancer survivors. It includes an intake session followed by individual and group sessions focused on exercise and lifestyle changes, concluding with a graduation.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Health Behavior ProgramExperimental Treatment5 Interventions
Each participant will have an individualized assessment with plan and goals set at the program intake visit. Program components will include: Physical Activity, Nutrition, Emotional Well-being, Cardiovascular Risk, Survivorship, and other items individualized to the participant as needed (e.g., tobacco cessation). The 12-week program will alternate between group and individual sessions each week. Individualized plans will be reviewed every two weeks at the participant individual sessions.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

Findings from Research

Older breast cancer survivors (n = 1361) do not have a significantly higher risk of cardiovascular disease (CVD) compared to matched women without breast cancer, indicating that breast cancer status alone is not a strong predictor of CVD risk.
The study highlights that preexisting conditions like smoking, diabetes, and hypertension are much stronger predictors of CVD risk, suggesting that managing these comorbidities is crucial for improving long-term health outcomes in breast cancer survivors.
Comorbidities and cardiovascular disease risk in older breast cancer survivors.Haque, R., Prout, M., Geiger, AM., et al.[2022]
The ACTIVATE Trial demonstrated that using a Garmin Vivofit 2 activity monitor, along with behavioral coaching, significantly increased moderate to vigorous physical activity (MVPA) by an average of 69 minutes per week in breast cancer survivors over a 12-week period.
Participants in the intervention group also experienced a significant reduction in sedentary behavior, with decreases of 37 minutes per day in total sitting time and 42 minutes per day in prolonged sitting bouts, highlighting the effectiveness of wearable technology in promoting a more active lifestyle.
A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial.Lynch, BM., Nguyen, NH., Moore, MM., et al.[2020]
The BEAT Cancer intervention significantly improved key social cognitive factors such as self-efficacy, goal setting, and perceived barriers to physical activity among 222 post-treatment breast cancer survivors over a 3-month period.
Despite these improvements in social cognitive constructs, the intervention did not lead to significant indirect effects on increasing physical activity levels measured 6 months after the intervention.
Social Cognitive Constructs Did Not Mediate the BEAT Cancer Intervention Effects on Objective Physical Activity Behavior Based on Multivariable Path Analysis.Rogers, LQ., Courneya, KS., Anton, PM., et al.[2021]

References

Comorbidities and cardiovascular disease risk in older breast cancer survivors. [2022]
A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial. [2020]
Social Cognitive Constructs Did Not Mediate the BEAT Cancer Intervention Effects on Objective Physical Activity Behavior Based on Multivariable Path Analysis. [2021]
Effect of a 12-Week Online Walking Intervention on Health and Quality of Life in Cancer Survivors: A Quasi-Randomized Controlled Trial. [2019]
A qualitative evaluation of breast cancer survivors' acceptance of and preferences for consumer wearable technology activity trackers. [2022]
Prevention and Treatment of Cardiac Dysfunction in Breast Cancer Survivors. [2016]
Coronary heart disease and mortality following a breast cancer diagnosis. [2023]
Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study. [2023]
Promoting Healthy Eating and Physical Activity Behaviors: A Systematic Review of Multiple Health Behavior Change Interventions Among Cancer Survivors. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Evaluation of a Mobile Health Intervention to Improve Wellness Outcomes for Breast Cancer Survivors. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security